<kbd id="6pv673qe"></kbd><address id="r302zu9v"><style id="gdqswc00"></style></address><button id="q6ifbdt4"></button>

          布伦顿湖桑德斯

          公司董事长,总裁兼首席执行官

          先生。桑德斯是董事长,总裁兼首席执行官眼力的,自2014年7月,自2016年十月董事长曾在总裁兼首席执行官的角色,在此之前曾担任首席执行官和总裁,并作为森林实验室主任,INC。 ,此前收购Allergan公司ITS。

          Prior to that, he served as Chief Executive Officer of Bausch + Lomb Incorporated, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Mr. Saunders also held a number of leadership positions at Schering-Plough, including the position of President of Global Consumer Health Care and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Mr. Saunders was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at 主页 Care Corporation of America. Mr. Saunders began his career as Chief 合规 Officer for the Thomas Jefferson University Health System. Mr. Saunders serves on the Board of Directors of Cisco Systems, Inc. and The Allergan Foundation, and is a member of the Business Council, the Business Roundtable and PhRMA.

          Brent Saunders

              <kbd id="3ezdlhny"></kbd><address id="4dyplydv"><style id="8g7i4n9r"></style></address><button id="bag45suy"></button>